N-(5-methylsulfanyl-4h-[1,2,4]triazol-3-yl)-4-phenoxy -benzenesulfonamide

Catalog No. :
ACWHBY356
CAS No. :
1021088-95-8
Molecular Formula :
C15H14N4O3S2
Molecular Weight :
362.44

IUPAC Name:N-(3-(methylthio)-1H-1,2,4-triazol-5-yl)-4-phenoxybenzenesulfonamide

N-(5-methylsulfanyl-4h-[1,2,4]triazol-3-yl)-4-phenoxy  -benzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(5-methylsulfanyl-4h-[1,2,4]triazol-3-yl)-4-phenoxy -benzenesulfonamide
IUPAC NameN-(3-(methylthio)-1H-1,2,4-triazol-5-yl)-4-phenoxybenzenesulfonamide
MDL No.MFCD11226343
Molecular FormulaC15H14N4O3S2
Molecular Weight362.44
SMILESO=S(C1=CC=C(OC2=CC=CC=C2)C=C1)(NC3=NN=C(SC)N3)=O
InChI KeyLKOBQIWHLVHNFN-UHFFFAOYSA-N
SynonymN-[5-(methylsulfanyl)-4H-1,2,4-triazol-3-yl]-4-phenoxybenzene-1-sulfonamide;Benzenesulfonamide, N-[5-(methylthio)-1H-1,2,4-triazol-3-yl]-4-phenoxy-
CAS No.1021088-95-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWHBY356 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRPFW239 route compound structure diagram
    ACRPFW23945534-08-5 In Stock
  2. Plus
  3. ACRYBL837 route compound structure diagram
    ACRYBL8371623-92-3 In Stock
  4. Then
  5. ACWHBY356 route product structure diagram
    ACWHBY3561021088-95-8
Inquiry

2. ACWHBY356 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPBYR859 route compound structure diagram
    ACPBYR859100-67-4
  4. Then
  5. ACWHBY356 route product structure diagram
    ACWHBY3561021088-95-8
Inquiry

Comments (0)